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Abstract
Background: Klebsiella pneumoniae is an important gram-negative opportunistic pathogen causing primarily urinary 
tract infections, respiratory infections, and bacteraemia. The ability of bacteria to form biofilms on medical devices, e.g. 
catheters, has a major role in development of many nosocomial infections. Most clinical K. pneumoniae isolates express 
two types of fimbrial adhesins, type 1 fimbriae and type 3 fimbriae. In this study, we characterized the role of type 1 and 
type 3 fimbriae in K. pneumoniae biofilm formation.
Results: Isogenic fimbriae mutants of the clinical K. pneumoniae isolate C3091 were constructed, and their ability to 
form biofilm was investigated in a flow cell system by confocal scanning laser microscopy. The wild type strain was 
found to form characteristic biofilm and development of K. pneumoniae biofilm occurred primarily by clonal growth, 
not by recruitment of planktonic cells. Type 1 fimbriae did not influence biofilm formation and the expression of type 1 
fimbriae was found to be down-regulated in biofilm forming cells. In contrast, expression of type 3 fimbriae was found 
to strongly promote biofilm formation.
Conclusion: By use of well defined isogenic mutants we found that type 3 fimbriae, but not type 1 fimbriae, strongly 
promote biofilm formation in K. pneumoniae C3091. As the vast majority of clinical K. pneumoniae isolates express type 
3 fimbriae, this fimbrial adhesin may play a significant role in development of catheter associated K. pneumoniae 
infections.
Background
Klebsiella pneumoniae is an important gram-negative
opportunistic pathogen causing primarily urinary tract
infections (UTIs), respiratory infections and bacteraemia
especially in immunocompromised individuals [1]. Next
to Eschericia coli, K. pneumoniae is one of the most fre-
quent causes of catheter-associated urinary tract infec-
tions (CAUTIs). The high incidence of CAUTIs has
significant costs. Besides the economic aspect due to
extended hospital admission days, the infection can
spread to the kidneys and bloodstream causing systemic
disease including bacteraemia [2-5].
The ability of bacteria to form biofilms on medical
devices, e.g. catheters, is believed to play a major role in
development of nosocomial infections including CAUTIs
[2,5-7]. Biofilm formation, i.e. bacteria form an organized
matrix-enclosed community adhering to the surface and
each other, provides enhanced tolerance to antibiotics
and the host immune system compared to growth as
planktonic cells. Adhesion to the surface is the first essen-
tial step in biofilm formation; but adhesins may also play
a significant role in later steps of biofilm development,
e.g. by promoting cell-cell contact. Indeed, various fim-
brial adhesins have been shown to play a role in biofilm
formation in different bacterial species including E. coli,
Pseudomonas aeruginosa, Vibrio cholera and Vibrio para-
haemolyticus [8-12]. Most K. pneumoniae isolates express
two types of fimbrial adhesins, type 1 and type 3 fimbriae
[1]. Type 1 fimbriae are found in the majority of enter-
obact e rial  species;  t hey m edia t e  a dhes io n t o  m annose -
containing structures and their expression is phase vari-
able, i.e. mediated by an invertible DNA element (fim
switch) [13]. Type 3 fimbriae are present in practically all
K. pneumoniae isolates and mediate adhesion to several
cell types in vitro [14,15]; nevertheless, the receptor for
type 3 fimbriae has not yet been identified. Historically,
type 3 fimbriae have not been associated with E. coli ;
however most recently two independent studies have for
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the first time reported type 3 fimbriae expression in E.
coli strains encoded by conjugative plasmids [16,17].
W e most recently investigated the role of type 1 and
type 3 fimbriae in K. pneumoniae virulence in a UTI, a
lung infection, and a gastrointestinal colonization model
[18,19]. Type 1 fimbriae were found to be essential for the
ability of K. pneumoniae to cause UTI, whereas type 3
fimbriae were not essential for virulence in the tested ani-
mal models [18,19]. In the present study we assessed the
role of type 1 and type 3 fimbriae in K. pneumoniae bio-
film formation.
Methods
Bacterial strains and growth conditions
K. pneumoniae C3091 is a clinical urinary tract infection
isolate expressing type 1 and type 3 fimbriae [20,21]. The
isogenic C3091 type 1 fimbriae mutant (C3091Δfim),
type 3 fimbriae mutant (C3091Δmrk) and type 1 and type
3 fimbriae double mutant (C3091ΔfimΔmrk) were previ-
ously described including verification of expected fim-
brial expression [18,19]. Unless otherwise stated, bacteria
were cultured at 37°C on solid or liquid Luria-Bertani
(LB) medium. When appropriate, media were supple-
mented with the following concentrations of antibiotics:
apramycin, 30 μg/ml; and chloramphenicol, 30 μg/ml.
Construction of fluorescently-tagged strains
To observe biofilm formation by confocal laser scanning
microscopy (CLSM), the C3091 wild type and its fim-
briae-mutants were chromosomally-tagged by allelic
exchange of the lacIZ genes with a cassette encoding flu-
orescent protein (yellow fluorescent protein (YFP) or
cyan fluorescent protein (CFP)) under control of the
modified lac promotor PA1/04/03, and chloramphenicol
resistance flanked by regions homologous to regions up-
and down-stream the lacIZ genes. The cassette was gen-
erated by a modification of a three-step PCR procedure
as previously described [18,19,22]. All primers used are
listed in Table 1. As the first step, the fluorescent protein
and chloramphenicol encoding cassette was amplified
from pAR116 (YFP) or pAR145 (CFP) using primer pair
Ucas and Dcas [23]. Secondly, from C3091 chromosomal
DNA a 403 bp region and a 460 bp region flanking the
lacIZ genes, were amplified by PCR using primer pairs
lacIUp-F, lacIUp-R and lacZDw-F, lacZDw-R, respec-
tively. At their 5' ends, primer lacIUp-R and primer and
lacZDw-F contained regions homologous to the primers
Ucas and Dcas, respectively. In the third step, the flank-
ing regions were added on each side of the fluorescent
protein and chloramphenicol resistance cassette by mix-
ing 100 ng of each fragment, followed by PCR amplifica-
tion using primer pair lacIUp-F and lacZDw-R. The PCR
product was purified and electroporated into C3091 wild
type or its fimbriae mutants harboring the thermo-sensi-
tive plasmid pKOBEGApra encoding the lambda Red
recombinase. The fluorescently tagged strains were
selected by growth on LB plates containing chloramphen-
icol at 37°C. Loss of the pKOBEGApra plasmid was veri-
fied by the inability of the tagged strains to grow on LB
agar plates containing apramycin. Correct allelic
exchange was verified by PCR analysis using primer pair
UplacI and DwlacZ flanking the lacIZ region.
Flow chamber biofilms
Biofilms were grown in flow chambers with individual
channel dimensions of 1 × 4 × 40 mm supplied with mod-
ified FAB medium [8]. The modified FAB medium was
supplemented with glucose (100 mg l-1) as carbon source
and isopropyl-thio-beta-galactoside (IPTG; 12 mg l-1) to
ensure expression of fluorescent proteins from the PA1/04/
03 promotor. The flow system was assembled and pre-
pared as described previously [24]. A microscope cover
slip of borosilicate (Knittel 24 × 50 mm st1; Knittel
Gläser) was used as substratum. The flow chambers were
inoculated by injecting approximately 2 × 106 cells, into
each flow chamber with a small syringe. After inocula-
tion, the flow chambers were left without flow for 1 h,
and medium flow (0.2 or 0.8 mm s-1 corresponding to
laminar flow and Re numbers of 0.3 and 1.3, respectively)
was started using a Watson Marlow 205 S peristaltic
pump and the system was incubated at 30°C.
Microscopy and image acquisition
Biofilm formation was monitored by CLSM four, 24, 48,
and 72 hours after inoculation. Microscopic observations
and image acquisitions were performed with a Zeiss LSM
510 CLSM (Carl Zeiss, Jena, Germany) using a 40 ×/1.3
oil objective. The microscope was equipped with lasers,
detectors and filter sets for detecting CFP and YFP fluo-
Table 1: Primers used in this study
Primer name Sequence 5' 3'
UCas CAAGAATTGCCGGCGGAT
DCas GGTATTTCACACCGCATAGC
lacIUp-F GCTGGAAGTAAAGGCTGTCG
lacIUp-R ATCCGCCGGCAATTCTTGTCCGGATATGGCC
TGCCTGTTTCT
lacZDw-F GCTATGCGGTGTGAAATACCAGCTGTTGACT
CCCCTGCGTGACC
lacZDw-R TTTCCGTCGGGAAGATGTAG
UplacI GCTCCACCGCCCTTTTG
DwlacZ GTCGCCCCCACGGATTA
CAS168 GGGACAGATACGCGTTTGAT
CAS169 GGCCTAACTGAACGGTTTGASchroll et al. BMC Microbiology 2010, 10:179
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rescence. Simulated three-dimensional images were gen-
erated using the IMARIS software package (Bitplane AG,
Zürich, Switzerland).
Quantification of biofilm formation and statistical analysis
For quantitative analysis of the biofilms, CLSM images
were analysed by the computer program COMSTAT [25].
The total amount of biomass on the surface, the relative
substratum coverage and the average thickness of the bio-
film were calculated. Differences between the wild type
and each mutant in the three parameters were compared
by using a two-tailed independent t-test. P values below
0.05 were considered to be statistically significant.
Fimbrial switch orientation assay
A modification of a previously described method was
used to determine the orientation of the fim-switch in K.
pneumoniae  biofilms [18,26]. Biofilm samples were
obtained by aspiration of the biofilm from individual flow
cell channels by use of a syringe. All inoculum and bio-
film samples were boiled for 5 min in PBS immediately
after collection and then kept at -20°C until use. After
thawing, the samples were boiled for 5 min, centrifuged
at 12,000 g for 15 min and 2 μl of the supernatant used as
template for PCR. Primers CAS168 and CAS169 (Table
1) were used to amplify an 817 bp region containing the
fim-switch by use of the Expand High Fidelity PCR Sys-
tem (Roche). The PCR cycle conditions were as follows: 1
cycle of 94°C for 2 min; 30 cycles of 94°C for 15 s, 52°C for
1 min, 72°C for 1 min; one cycle of 72°C for 7 min. The
PCR products were cut with HinfI and separated on a
1.2% agarose gel. Due to asymmetric location of the HinfI
cleavage site inside the invertible element, different sized
DNA fragments are obtained depending on the orienta-
tion of the phase switch.
Results
Role of fimbriae in K. pneumoniae biofilm formation by 
investigating monoculture biofilms
To investigate the role of type 1 and type 3 fimbriae in K.
pneumoniae  biofilm formation a well-defined isogenic
type 1 fimbriae mutant (C3091Δfim), a type 3 fimbriae
mutant (C3091Δmrk), and a type 1 and 3 fimbriae double
mutant (C3091ΔfimΔmrk) of the clinical UTI isolate
C3091 were used. The wild type and its fimbriae mutants
were found to have similar growth rates in the modified
FAB medium used for biofilm experiments (results not
shown).
Biofilm formation was observed four hours after inocu-
lation of bacteria and after one, two, and three days. Four
hours after inoculation of the flow-system, single cells of
the wild type strain and its type 1 fimbriae mutant were
observed adhering to the substratum whereas only very
few cells of the type 3 fimbriae and the type 1 and 3 fim-
briae double mutant were detected (results not shown).
After 24 hours the wild type and the type 1 fimbriae
mutant were found to form characteristic biofilms on the
substratum observed as long extended colonies in the
flow direction (Figure 1).
In contrast, the type 3 fimbriae mutant and the type 1
and 3 fimbriae double mutant only formed distinct
microcolonies. Thus type 3 fimbriae, but not type 1 fim-
briae, are important for attachment to the substratum as
well as the initial stages of biofilm formation.
Effect of flow on biofilm formation
To investigate the influence of shear forces on biofilm for-
mation, a similar experiment was performed, except the
media flow speed was raised from 0.2 mm/s to 0.8 mm/s.
Under higher flow speed, the influence of type 3 fimbriae
was even more pronounced (Figure 2). The two mutants
unable to express type 3 fimbriae (C3091Δmrk  and
C3091ΔfimΔmrk) formed even fewer and smaller colo-
nies. Also the biofilm formation of the wild type and the
type 1 fimbriae mutant was influenced by the higher flow
speed. Both cell types formed flat biofilms compared to
biofilms under lower flow velocity, likely due to increased
removal of loosely attached cells. However, the biofilms
were significantly more pronounced and continuous and
covered most of the surface compared to the biofilms of
the type 3 fimbriae mutant and the type 1 and 3 fimbriae
double mutant (Figure 2). In some areas the wild type and
type 1 fimbriae mutant covered the whole surface as seen
in Figure 2 and in other areas they formed the long
extended colonies in the flow direction as observed under
lower flow speed. This heterogeneity may be related to
small differences in the flow cell micro-environment
including lower flow stress due to presence of upstream
biofim.
Biofilm formation by wild type and mutants in competition
To further characterize the influence of fimbriae on K.
pneumoniae  biofilm formation, flow cell experiments
were performed with the different fimbriae mutants in
direct competition with the wild type strain. For these
experiments the wild type strain was chromosomally-
tagged with cyan fluorescent protein (CFP). To verify that
the YFP- and CFP-tagging did not have any influence on
the biofilm formation, equal amounts of the YFP- and
CFP-tagged wild type variants were inoculated in the
same flow cell. As seen in Figure 3A, the biofilm forma-
tion of the YFP- and CFP-labelled wild types was similar.
Furthermore, the results indicate that the K. pneumoniae
biofilm develops primarily by clonal growth and not by
recruitment of planktonic cells, as the biofilm was formed
by large colonies of either YFP or CFP labelled cells. If the
biofilm was developed by recruitment of planktonic cells,Schroll et al. BMC Microbiology 2010, 10:179
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there would be a mix of YFP- and CFP-labelled cells in
the colonies of the biofilm.
Competition experiments with the wild type and type 1
fimbriae mutant revealed that biofilm formation by the
mutant strain were similar to the wild type (Figure 3B).
As competition experiments are expected to reveal even
minor differences in the ability to form biofilm, this veri-
fies that type 1 fimbriae do not play a role in K. pneumo-
niae biofilm formation. In contrast the experiments with
the C3091Δmrk and C3091ΔfimΔmrk mutants in compe-
tition with the wild type show a pronounced difference in
biofilm formation (Figure 3C and 3D). In both cases the
biofilm was formed by the wild type strain and only few
small patches of the mutant strains were detected. Thus,
the competition experiments confirmed that type 3 fim-
briae are essential for K. pneumoniae biofilm formation.
Quantitative analysis of biofilm formation by wild type and 
mutants
The computer program, COMSTAT [25], was used to
quantitatively analyse the biofilm formed by the wild type
and its fimbriae mutants. Three different parameters,
biomass, substratum coverage, and average thickness,
were calculated from CSLM images of biofilms formed
one, two and three days after inoculation. The average
biofilm biomass level and thickness did differ over the
three day period indicating continuous biofilm develop-
ment and adaptation during the time period. At all time-
points, the wild type and the type 1 fimbriae mutant
formed significantly more biomass per surface area than
the two mutants lacking the ability to form type 3 fim-
briae (C3091Δmrk and C3091ΔfimΔmrk) (Figure 4A). No
significant differences in biomass were detected between
Figure 1 One-day old biofilms of K. pneumoniae C3091 and its isogenic fimbriae mutants at flow 0.2 mm/s. Biofilm formation was examined 
in three independent experiments with similar results. Box sides 230 μm × 230 μm.Schroll et al. BMC Microbiology 2010, 10:179
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the wild type and the type 1 fimbriae mutant in the 1-3
days old biofilms. In contrast, a highly significant differ-
ence in biomass between the wild type and the type 3
fimbriae mutant (P < 0.01) and the type 1 and type 3 fim-
briae double mutant was observed at all timepoints (P <
0.01).
Also the substratum coverage was significantly reduced
for the type 3 fimbriae mutants in the 1-3 days old bio-
films (Figure 4B). Both the type 3 fimbriae mutant and
the type 1 and 3 fimbriae double mutant exhibited a
much lower substratum coverage than the wild type (P <
0.01), whereas there was no significant difference
between the wild type and the type 1 fimbriae mutant.
The average thickness of the 1-3 days old biofilms
formed by the type 3 fimbriae mutant and the type 1 and
3 fimbriae mutant was also significantly lower than for
the wild type (Figure 4C) (P < 0.01), while there was no
significant difference between the wild type and the type
1 fimbriae mutant. Thus type 3 fimbriae do not only
mediate cell-surface attachment to the substratum, but
are also important for cell-cell adherence.
Complementation by type 3 fimbriae restores biofilm 
formation of the mutant
To verify that the attenuated biofilm formation of the
type 3 fimbriae mutants was due to abolishment of type 3
fimbriae expression and not polar effects of the mutation,
the type 3 fimbriae mutant was transformed with
pCAS630 containing the C3091 mrk gene cluster [19]. In
contrast to the type 3 fimbriae mutant, the comple-
mented mutant exhibited pronounced biofilm formation
confirming the significant role of type 3 fimbriae in K.
pneumoniae biofilm formation (Figure 5). In fact, the bio-
film formation was even more prominent than for the
Figure 2 One-day old biofilms of K. pneumoniae C3091 and its isogenic fimbriae mutants at flow 0.8 mm/s. Biofilm formation was examined 
in three independent experiments with similar results. Box sides 230 μm × 230 μm.Schroll et al. BMC Microbiology 2010, 10:179
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wild type strain, likely due to enhanced type 3 fimbriae
expression from the plasmid vector.
Type 1 fimbriae expression is down-regulated in K. 
pneumoniae biofilms
Expression of K. pneumoniae type 1 fimbriae is regulated
by phase variation mediated by an invertible DNA ele-
ment (fim-switch). To investigate the expression of type 1
fimbriae during biofilm formation, the orientation of the
fim-switch in cells forming biofilm was compared with
the orientation in the bacterial suspension used to inocu-
late the flow-cells. The switch orientation was investi-
gated for the wild type as well as the type 3 fimbriae
mutant. In the inoculum suspension of the wild type, only
fragments corresponding to the switch orientation in the
"off" orientation were detected (Figure 6). Also in the
cells from wild type biofilm only the "off" orientation was
detected.
Interestingly, in the inoculum suspension of the type 3
fimbriae mutant both the "on" and the "off" orientation
was detected, indicating that abolishment of type 3 fim-
briae expression leads to up-regulation of type 1 fimbriae
expression. However, as for the wild type, only the "off"
orientation was detected in type 3 fimbriae mutant bio-
films. Thus, type 1 fimbriae expression was established to
be down-regulated in K. pneumoniae biofilms even when
the biofilm forming strains were unable to produce type 3
fimbriae.
Discussion
The role of K. pneumoniae type 1 and type 3 fimbriae in
vivo was recently investigated by our group [18,19]. Type
1 fimbriae were established to be an essential virulence
factor in K. pneumoniae UTI whereas expression of type
3 fimbriae had no influence on pathogenicity in an UTI
animal model. Furthermore, neither type 1 fimbriae nor
type 3 fimbriae were found to influence the ability to col-
onize the intestinal tract or cause lung infection. The vir-
ulence studies were conducted by use of non-complicated
mouse models and it could be speculated that the influ-
ence of fimbrial expression on virulence may be different
Figure 3 Competition biofilm experiments with K. pneumoniae C3091 and its isogenic fimbriae mutants. The pictures are of one day old bio-
films. All biofilms were initiated with a 1:1 mixture of CFP-tagged and YFP-tagged bacteria. Biofilm formation was examined in three independent ex-
periments with similar results. Box sides 230 μm × 230 μm.Schroll et al. BMC Microbiology 2010, 10:179
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in complicated infections, e.g. infections related to use of
indwelling devices such as catheters [18,19]. It is well
known that many pathogenic bacteria form biofilms on
catheter surfaces, therefore we have in the present study
characterized the influence of type 1 and type 3 fimbriae
on K. pneumoniae biofilm formation.
The K. pneumoniae wild type strain was found to form
characteristic biofilms in a continuous flow system. Sin-
gle cells attached to the substratum followed by prolifera-
tion whereby micro-colonies were formed. Spread of the
biofilm likely occurs by release of cells from the micro-
colonies that subsequently attach to the substratum
down-stream of the colony whereby characteristic long
colonies are formed in the flow direction. In competition
experiments, where the flow chambers were incubated
with equal number of different colour-tagged isolates
(YFP- and CFP-tagged), the colonies in the biofilms con-
sisted of either yellow (YFP)- or blue (CFP) -tagged cells,
rather than a mix of two colours (Figure 3). This indicates
that recruitment of planktonic cells does not play a signif-
icant role in K. pneumoniae biofilm development. If
recruitment of planktonic cells played a major role, the
biofilm would be a mix of YFP- and CFP-tagged cells.
Thus, our results reveal that development of K. pneumo-
niae biofilm occurs primarily by clonal growth.
The type 1 fimbriae mutant was found to be an as effec-
tive biofilm former as the wild type strain. Even when
inoculated simultaneously with the wild type, the type 1
fimbriae mutant formed as much biofilm as the parent
strain. Also quantitative analysis of the biofilms, using the
computer program COMSTAT, revealed no significant
difference in biomass, substratum coverage, and average
thickness of the biofilm between the wild type and the
type 1 fimbriae mutant. Equal amounts of substratum
coverage indicate that type 1 fimbriae are not directly
involved in cell-surface attachment. Furthermore, the
similar biofilm biomass and thickness demonstrates that
type 1 fimbriae are not involved in cell-cell adherence in
the biofilm. Cover slips of borosilicate were used as sub-
stratum in our study and it can not be excluded that type
1 fimbriae may play a role in biofilm formation on other
substratums.
It was most intriguing, that type 1 fimbriae was not
involved in biofilm formation as type 1 fimbriae are an
essential virulence factor in K. pneumoniae urinary tract
infection [18,19] and seen to promote biofilm formation
in E. coli [10,27]. Therefore, we investigated whether this
lack of impact of type 1 fimbriae on biofilm formation
was related to down-regulation of fimbrial expression.
Type 1 fimbriae expression is regulated by the fim-switch
containing the promoter for the major fimbrial subunit
fimA [28]. The orientation of the fim-switch was investi-
gated, in order to assess whether type 1 fimbriae were
expressed during biofilm formation. Only the "off" orien-
tation was detected from the C3091 wild type, demon-
strating that type 1 fimbriae are down-regulated in
biofilm forming cells. In contrast to the wild type, both
the "on" and the "off" orientation was detectable in the
i n o c u l u m  s u s p e n s i o n  o f  t h e  t y p e  3  f i m b r i a e  m u t a n t s .
Thus, abolishment of type 3 fimbriae expression was
compensated by up-regulation of type 1 fimbriae, indicat-
ing cross-regulation of the two fimbrial gene clusters. We
recently reported that the two fimbrial gene clusters are
situated in close proximity on the K. pneumoniae chro-
Figure 4 Quantitative analysis of biofilm formation by K. pneu-
moniae C3091 and its isogenic fimbriae mutants at different 
time-points by use of the computer program COMSTAT. A. Bio-
mass. B. Substratum coverage (1 represents total coverage). C. Average 
thickness of biofilm. The mean and standard errors of the means are 
shown. Values were calculated from analysis of a minimum of seven 
images.Schroll et al. BMC Microbiology 2010, 10:179
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mosome, only interspaced by a 4.6 kb region which
encodes putative regulatory genes [19]. Experiments to
elucidate the putative cross-regulation of type 1 and type
3 fimbriae expression have been initiated in our group.
Although the type 3 fimbriae mutant expressed type 1
fimbriae in the suspension used to inoculate the flow
chambers, only the "off" orientation was detected from
the biofilm. Thus, even though the mutant was unable to
express type 3 fimbriae, type 1 fimbrial expression was
down-regulated, emphasizing that type 1 fimbriae do not
play a significant role in biofilm formation. We previously
demonstrated that type 1 fimbrial expression is up-regu-
lated in wild type K. pneumoniae C3091 cells infecting
the bladder (only "on" orientation detectable) but are
down-regulated in C3091 cells colonizing the intestinal
tract as well as when infecting the lungs (only "off" orien-
tation detectable) [18]. That the fim-switch in different
scenarios, including biofilms, are only detected in the
"off" or the "on" orientation indicates either that specific
environmental signals induce switching to either the "on"
or "off" position or alternatively, that the specific environ-
ments provoke a strong selection for either fimbriated or
non-fimbriated bacteria. In our experiments, if expres-
sion of type 1 fimbriae promoted biofilm formation, a
selection of type 1 fimbriae producing variants, would be
expected to occur during biofilm formation. This would
especially be the case for the type 3 fimbriae mutant as
cells expressing type 1 fimbriae were already present in
bacterial suspension used to inoculate the flow chambers.
To our knowledge this is the first study which has inves-
tigated the influence of type 1 fimbriae on K. pneumoniae
biofilm formation by use of well-defined isogenic
mutants. It may be argued that the role of type 1 fimbriae
in biofilm formation may be strain specific. However,
supporting our findings, a previous study testing pheno-
typic expression of type 1 fimbriae in various K. pneumo-
niae  isolates found that biofilm formation on plastic
surfaces was not correlated with type 1 fimbrial expres-
sion [29].
In E. coli , a very close relative to K. pneumoniae , type 1
fimbriae have been shown to promote biofilm formation
[10,27]. We are speculating that this intriguing difference
may be related to the characteristic production of copious
amounts of capsular material by K. pneumoniae strains.
Indeed, it has been demonstrated that the presence of
capsule is important for K. pneumoniae biofilm establish-
ment and maturation [30]. Furthermore, capsule expres-
sion has been shown to inhibit type 1 fimbriae
functionality [31,32]. Thus, it could be speculated, that
up-regulation of capsule expression during biofilm for-
mation inhibits type 1 fimbriae functionality, therefore
type 1 fimbriae expression is down-regulated. Both the
C3091 wild type and its fimbriae mutants are pro-
nouncedly capsulated when grown on agar plates. We
have initiated experiments to investigate the cross-regu-
lation between capsule and fimbrial expression during K.
pneumoniae biofilm formation.
I n  c o n t r as t  t o  t ype  1  f i m b r i a e ,  t ype  3  f i m b r i a e  w e r e
found to play an essential role in K. pneumoniae C3091
Figure 5 Comparison of biofilm formation by the wild type, type 3 fimbriae mutant, and the type 3 fimbriae mutant transformed with 
pCAS630 containing the type 3 fimbriae gene cluster. Biofilm formation was examined in three independent experiments with similar results. Box 
sides 230 μm × 230 μm.
Figure 6 Orientation of the fim phase switch in inoculum suspen-
sions and biofilms of the wild type and type 3 fimbriae mutant 
(Δmrk). Lane M contained molecular size markers. Lane 1, wild type In-
oculum; lane 2, wild type biofilm; lane 3, Δmrk inoculum; lane 4, Δmrk 
biofilm. The lower band intensity in lane 4 is likely related to the low 
level of biofilm formed by the type 3 fimbriae mutant.Schroll et al. BMC Microbiology 2010, 10:179
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biofilm formation. The type 3 fimbriae mutants formed
only sparse biofilms in the flow chambers and were
essentially outcompeted when in direct competition with
the wild type. The COMSTAT results for both the type 3
fimbriae mutant and type 1 and 3 fimbriae double mutant
revealed much lower substratum coverage than the wild
type. This indicates that type 3 fimbriae are most impor-
tant for initial cell-surface attachment. Furthermore, the
lower amount of biomass and average thickness of the
biofilms for the type 3 fimbriae mutants compared to the
wild type and type 1 fimbriae mutant indicates that type 3
fimbriae also mediates cell-cell adherence in the biofilm.
Our results confirm previous studies demonstrating that
type 3 fimbriae are important for K. pneumoniae biofilm
formation [29,33]. Also in E. coli , the recently discovered
ability to express type 3 fimbriae, mediated by conjuga-
tive plasmids, was found to profoundly enhance biofilm
formation [16,17]. Thus, type 3 fimbriae expression
seems to generally promote biofilm formation in different
bacterial species.
We have previously established that type 1 fimbriae but
not type 3 fimbriae are an essential virulence factor in K.
pneumoniae urinary tract infections [18,19]. The present
study demonstrates how the impact of a specific viru-
lence factor may vary significantly in different infection
scenarios and host environments. Thus, although type 3
fimbriae may not be significantly involved in develop-
ment of uncomplicated UTIs, our results indicates that
type 3 fimbriae may be a significant virulence factor in
CAUTIs since they promote biofilm formation on inert
surfaces. Understanding the mode of bacterial growth in
vivo during infection is important in relation to future
therapeutic measures.
Conclusions
In conclusion, the present work shows that type 3 fim-
briae, but not type 1 fimbriae, mediate biofilm formation
in  K. pneumoniae C3091. As type 3 fimbriae promote
adhesion to abiotic surfaces and biofilm formation in K.
pneumoniae  and other species, as shown here and by
other studies [16,17,29,33], type 3 fimbriae may generally
play a significant role in development of catheter related
infections such as CAUTIs. In this respect, the occur-
rences of conjugative plasmids encoding type 3 fimbriae
in other species are worrisome.
As the vast majority of K. pneumoniae isolates are able
to express both type 1 and type 3 fimbriae [1], the use of
epidemiological studies to elucidate the role of fimbriae
in catheter associated K. pneumoniae infections is diffi-
cult. Thus further studies using catheterized in vivo
infection models, are needed to further characterize the
role of fimbriae in catheter related infections.
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